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https://doi.org/10.1016/j.celrep.2021.108690SUMMARYHallmarks of mature b cells are restricted proliferation and a highly energetic secretory state. Paradoxically,
cyclin-dependent kinase 2 (CDK2) is synthesized throughout adulthood, its cytosolic localization raising the
likelihood of cell cycle-independent functions. In the absence of any changes in b cell mass, maturity, or pro-
liferation, genetic deletion of Cdk2 in adult b cells enhanced insulin secretion from isolated islets and
improved glucose tolerance in vivo. At the single b cell level, CDK2 restricts insulin secretion by increasing
KATP conductance, raising the set point for membrane depolarization in response to activation of the phos-
phoenolpyruvate (PEP) cycle with mitochondrial fuels. In parallel with reduced b cell recruitment, CDK2 re-
stricts oxidative glucose metabolism while promoting glucose-dependent amplification of insulin secretion.
This study provides evidence of essential, non-canonical functions of CDK2 in the secretory pathways of
quiescent b cells.INTRODUCTION
Diabetes is associated with loss of functional b cell mass, and
there is growing interest in the therapeutic potential of re-initi-
ating the b cell mitogenic program (Ackeifi et al., 2020; Wang
et al., 2019), which is typically active only in the first few months
of life in mice and a year or two in humans (Cozar-Castellano
et al., 2006). However, cyclin-dependent kinases (CDKs) and
their cognate cyclins, having a half-life of hours, are re-synthe-
sized continuously in b cells of adult mice and humans for their
entire lifespan (Fiaschi-Taesch et al., 2013), suggesting that
they perform non-canonical, non-cell cycle functions.
Most adult b cells remain quiescent in the G0/G1 phase of the
cell cycle and express CDK2, CDK4, and CDK6 (Cozar-Castel-
lano et al., 2006; Fiaschi-Taesch et al., 2013), which governs
the CDK-retinoblast protein (RB)-E2F pathway (Aguilar and Fa-
jas, 2010; Buchakjian and Kornbluth, 2010; DeBerardinis et al.,
2008). E2F transcription factors, normally bound by RB, are
released in response to RB phosphorylation by the CDKs. The
CDK-RB-E2F pathway has been linked genetically with changes
inmitochondrial mass, morphology, and bioenergetics (Blanchet
et al., 2011; Dali-Youcef et al., 2007; Goto et al., 2006; Hsieh
et al., 2008; Sakamaki et al., 2006), and multiple genetic deletion
studies have reported changes in insulin secretion (Annicotte
et al., 2009; Kim et al., 2017). In addition to transcriptionalC
This is an open access article under the CC BY-Nprograms, cell cycle regulators have been reported to regulate
extranuclear metabolic processes that may be unrelated to pro-
liferation (Gregg et al., 2019; Lagarrigue et al., 2016; Lee et al.,
2014; Lopez-Mejia et al., 2017; Wang et al., 2014). In support
of this idea, many if not most cell cycle regulators localize in
the cytosol rather than in the nucleus of adult b cells (Fiaschi-
Taesch et al., 2013).
Here, we targeted CDK2 to examine its relationship with the b
cell metabolic and secretory pathways. Deletion of the Cdk2
gene from the pancreatic endoderm in mice (i.e., Cdk2-flox-
ed:Pdx1-Cre) results in glucose intolerance because of reduced
insulin secretion (Kim et al., 2017). Importantly, this and other
previous studies of the CDK-RB-E2F pathway utilized embryonic
deletion models (i.e., Ccnd1/, Cdk4/, E2f1/) (Annicotte
et al., 2009; Blanchet et al., 2011; Dali-Youcef et al., 2007;
Goto et al., 2006; Hsieh et al., 2008; Kim et al., 2017; Sakamaki
et al., 2006; Xue et al., 2019), imposing chronic developmental
manipulations that may not be relevant in adults. To observe
CDK2 signaling in the context of a healthy adult b cell, we gener-
ated an inducible b cell-specific Cdk2 deletion mouse model
(CDK2-iKO,Cdk2-floxed:MIP-CreERT). Unlike the developmental
knockout, insulin secretion and glucose tolerance are enhanced
in CDK2-iKOmice. Using this model, we demonstrate pleotropic
regulation of b cell excitability, ion channels, oxidative meta-
bolism, and insulin secretion by CDK2 in adult b cells.ell Reports 34, 108690, January 26, 2021 ª 2021 The Author(s). 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Short-term CDK2 restriction enhances insulin secretion from mouse islets and improves glucose tolerance
(A) Mouse model used to inducibly delete CDK2 from adult b cells. Tamoxifen was injected intraperitoneally into Cdk2fl/fl-MIPCreER (CDK2-iKO) andMIP-CreERT
controls (Con) at 10 weeks of age. Mice were given 4 weeks to clear tamoxifen and phenotyped at 14 weeks of age.
(B) Cdk2 mRNA expression measured by qPCR in pancreatic islets isolated from Con (n = 15) and CDK2-iKO (n = 16) mice.
(C) CDK2 immunofluorescence (green) in a mouse pancreatic section.
(D) CDK2 (green) and insulin (pink) immunofluorescence in pancreatic sections from Con and CDK2-iKO mice.
(E) Glucose tolerance test (GTT) in Con (n = 5) and CDK2-iKO (n = 4) mice, quantified by area under the curve (AUC).
(F) Ex vivo glucose-stimulated insulin secretion (GSIS) normalized to insulin content, measured in isolated islets from Con (n = 3) and CDK2-iKO (n = 4) mice.
(G–I) Quantification of b cell mass (G), a cell mass (H), and Ki67-positive b cells (I) in Con (n = 4) and CDK2-iKO (n = 5) pancreatic sections.
(J–L) Insulin (pink) and maturation marker (green) GLUT2 (J), UCN3 (K), and MAFA (L) immunofluorescence in pancreatic sections from Con and CDK2-iKOmice.




Restricting CDK2 in adult b cells improves glucose
homeostasis and insulin secretion
To understand the role of CDK2 in adult b cells, we generated
CDK2-iKO mice by breeding Cdk2fl/fl mice (Kim et al., 2017;
Jayapal et al., 2015) with mice expressing tamoxifen-inducible
Cre recombinase using the mouse insulin promoter (MIP-
CreERT) (Tamarina et al., 2014; Figure 1A). Recombination
was induced at 10 weeks of age, and mice were analyzed at
14 weeks of age. In isolated islets, Cdk2 mRNA was reduced
by 70% in CDK2-iKO islets compared with MIP-CreERT controls2 Cell Reports 34, 108690, January 26, 2021(Figure 1B). In sectioned pancreas, we observed CDK2 primar-
ily in the cytosol of mature b cells (Figure 1C), corroborating
previous findings in human b cells (Fiaschi-Taesch et al.,
2013). We rarely observed b cells expressing CDK2 in CDK2-
iKO islets, confirming the efficacy of the MIP-CreERT transgene
(Figure 1D). In vivo, CDK2-iKO mice exhibited normal fasting
blood glucose, and glucose tolerance was improved significantly
(Figure 1E). Consistently, islets isolated from CDK2-iKO mice
secreted more insulin when challenged with glucose, whereas
no effect on insulin secretion was observed at basal glucose
levels (Figure 1F). No changes in a or b cell mass (Figures 1G




Figure 2. Reduced metabolic amplifying
pathway in CDK2-iKO b cells
(A and C) Capacitance increases in response to 10
step depolarizations from 70 mV to 0 mV in (A) b
cells (Con, n = 19; CDK2-iKO, n = 39) and (C) a cells
(Con, n = 14; CDK2-iKO, n = 14) isolated from 4 Con
and 3 CDK2-iKO mice.
(B and D) Averaged leak-subtracted calcium current
(ICa) and influx (QCa) from b cells (B) and a cells (D),
measured during a 15-ms step depolarization from
70 mV to 0 mV for each cell above.
(E) Ex vivo KCl-stimulated insulin secretion normal-
ized to DNA content, measured in isolated islets
from Con (n = 3) and CDK2-iKO (n = 4) mice,
quantified by AUC.
Data are shown as mean ± SEM. *p < 0.05, **p <




OPEN ACCESSinsulin content (data not shown) were observed. Thus, the
glucose homeostasis and insulin secretory phenotype in mice
with short-term CDK2 restriction is opposite of what was
observed in Cdk2fl/fl:Pdx1-Cre mice (Kim et al., 2017), indicating
that gain-of-function CDK2-iKO is a more appropriate genetic
model for understanding the role of CDK2 in adult b cells.
CDK2 is essential for glucose-dependent amplification
of insulin secretion
In b cells, glucose is a strong driver of several metabolic ampli-
fying pathways of insulin secretion (Prentki et al., 2013).
Consistent with a role of CDK2 in these pathways, we
observed a severe defect in insulin granule exocytosis in
CDK2-iKO islet b cells compared with controls (Figure 2A).
This secretion defect was not due to differences in calcium
channel activity (Figure 2B), nor was it observed in a cells
from CDK2-iKO islets, which retained full function (Figures 2C
and 2D). Importantly, we conducted these assays in the pres-
ence of 5 mM glucose, which is sufficient in capacitance as-
says to engage the b cell metabolic amplifying pathways at
80% maximum (Ferdaoussi et al., 2015), while avoiding electri-
cal activity in neighboring b cells that would otherwise
confound the capacitance measurements. KCl-stimulated in-
sulin secretion was also reduced significantly in CDK2-iKO is-
lets at a high glucose concentration without any significant
change at low glucose (Figure 2E). These findings demonstrate
that CDK2 is essential for glucose-dependent amplification ofC
insulin secretion; however, they cannot
explain the enhanced glucose tolerance
or glucose-stimulated insulin secretion
observed in CDK2-iKO mice.
CDK2 controls KATP channel activity
at the b cell plasma membrane
The CDK-RB-E2F pathway, through E2F1-
dependent transcription, has been shown
to directly regulate Kir6.2, which encodes
the pore-forming subunit of the KATP chan-
nel (Annicotte et al., 2009). In pharmaco-logic and genetic models of CDK2 restriction, we observed a
significant decrease in Kir6.2 mRNA (Figures 3A and 3C). To
determine whether CDK2 affects KATP channel function, we
measured b cell KATP conductance (GKATP) using patch-clamp
electrophysiology. GKATP was calculated from voltage ramps in
10 mM glucose and again in the presence of the KATP channel
opener diazoxide (200 mM) (Figures 3B and 3D). As a first
approach to CDK2 blockade, we used the small-molecule
CDK2 inhibitor SU9516 (CDK2i), which exhibits 2- and 10-fold
selectivity over CDK1 and CDK4, respectively (Lane et al.,
2001). GKATP was increased significantly by addition of diazo-
xide, as expected, and reduced in CDK2i-treated b cells relative
to vehicle controls (Figure 3B).
A limitation of using the MIP-CreERT recombination strategy is
incomplete penetrance of the Cre-mediated recombination (Fig-
ure 1B). To optimize our chances of recording from b cells with
restricted CDK2 signaling, we took advantage of adenovirally
delivered Cre recombinase. Islets were isolated from
Cdk2fl/fl:MIPCreERT or Cdk2wt/wt:MIPCreERT mice that had not
been injected with tamoxifen, dispersed into single cells, and
infected with Ad-Cre-IRES-GFP. GKATP was recorded from
GFP-expressing cells of both genotypes. Irrespective of the
treatment condition, GKATP was substantially lower in dispersed
b cells (Figure 3D) than in b cells within intact islets (Figure 3B).
Despite this difference, GKATP was reduced significantly in
adenovirally treated Cdk2fl/fl:MIPCreERT cells relative to
Cdk2wt/wt:MIPCreERT controls (Figure 3D), again demonstratingell Reports 34, 108690, January 26, 2021 3
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Figure 3. Islets with short-term CDK2 restric-
tion have reduced Kir6.2 mRNA, resulting in
reduced KATP channel activity
(A and C) Kcnj11 expression measured by qPCR in
pancreatic islets treated with vehicle Con or CDK2i
(n = 3 mice) (A) or islets isolated from Con and
CDK2-iKO mice (n = 3 mice per genotype) (C).
(B and D) Measurements of KATP conductance in
islets treatedwith vehicle Con or CDK2i (B) or CDK2-
iKO islets (C). Left: representative current-voltage
relationship collected during a voltage ramp,
showing conductance (slope) changes in b cells
measured in 10 mM glucose (10G) and after treat-
ment with 200 mM diazoxide (DZ). Right: KATP
conductance was reduced in CDK2i-treated (n = 7)
relative to vehicle-treated Con (n = 11) b cells (B) and
in CDK2-iKO b cells relative to Cons treatedwith Ad-
Cre (n = 11 cells from 3 mice each genotype) (D).
Data are shown as mean ± SEM. *p < 0.05, **p <
0.01, ***p < 0.001 by t test (A and C) or one-way
ANOVA (B and D).
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OPEN ACCESSthe functional decrease in KATP channel activity associated with
CDK2 deficiency.
Enhanced b cell recruitment in models of CDK2
blockade
The proportion of b cells that are electrically active, termed
recruitment, increases with glucose concentration as metaboli-
cally derived ATP/ADP closes KATP channels to reach the
threshold required for membrane depolarization (Jonkers and
Henquin, 2001; Lewandowski et al., 2020). Consequently, as
KATP channel activity is reduced, membrane depolarization and
calcium influx occur at a lower glucose concentration (Grape-
ngiesser et al., 1990; Gregg et al., 2016; Jonkers et al., 2001).
We measured cytosolic calcium to determine the extent to which
the reduced GKATP in CDK2-iKO islets caused a reduction in the
glucose threshold for b cell recruitment. Reflecting a lower
threshold, the duration of glucose-dependent calcium oscillations
was increased strongly in CDK2-iKO and CDK2i-treated islets
relative to controls (Figures 4A and 4E). An effect of CDK2 on b
cell recruitment was evidenced by failure of islet calcium oscilla-
tions to switch off at subthreshold glucose concentrations in
CDK2-iKO (Figure 4B) or CDK2i-treated islets (Figure 4F). We
also performed a more rigorous quantification of glucose-stimu-
lated calcium oscillations bymeasuring the oscillatory duty cycle,
the fractional time spent in the active, secretory phase of an oscil-
lation relative to the full cycle (Henquin, 2009; Lewandowski et al.,
2020). We observed an increase in the duty cycle of calcium
oscillations from CDK2-iKO and CDK2i islets relative to controls
(Figures 4C and 4G) together with increased oscillation frequency
(Figures 4D and 4H). These observations persisted when
islets were provided with fuels downstream of glucokinase,4 Cell Reports 34, 108690, January 26, 2021including glyceraldehyde (Figures 4I–4K),
and the mitochondrial fuel a-ketoisocap-
roate (aKIC) (Figures 4L–4N). These data
indicate b cell recruitment as a mechanism
that offsets the reduction in glucose-depen-
dent amplifying pathways in CDK2-iKOislets, contributing to enhanced glucose tolerance and glucose-
stimulated insulin secretion in this model.
Independent of glycolysis, amino acid-stimulated
phosphoenolpyruvate (PEP) cycling is sufficient to
enhance recruitment in CDK2-deficient b cells
Recently, pyruvate kinase (PK)-dependent PEP cycling was
demonstrated to generate the ATP/ADP that locally closes KATP
channels (Lewandowski et al., 2020). Importantly, there are two
sources of PEP in b cells: glycolytic enolase and mitochondrial
PCK2 (Figure 5A). At low glucose, when glycolytic enolase is inac-
tive, mitochondrial PEP production by PCK2 is required for amino
acid-stimulated, PK-dependent KATP closure and calcium influx
(Abulizi et al., 2020). Using this approach, calcium influx in
response to amino acids was found to be increased in CDK2-
iKO islets (Figures 5B and 5C). This effect persisted in the pres-
ence of a pharmacologic PK activator (Figures 5B and 5C) that
maximally activates thePEPcycle (Abulizi et al., 2020; Lewandow-
ski et al., 2020). These findings,matching the effects of the leucine
analog aKIC (Figures 4L–4N), indicate that amino acid-stimulated
PEP cycling contributes to enhanced b cell recruitment in the
CDK2-iKO model independent of glucose metabolism.
CDK2 depletion enhances oxidative glucose
metabolism
Any mechanism that increases b cell workload (i.e., ATP con-
sumption), including the increased calcium influx and insulin
secretion observed in CDK2-iKO islets, is expected to increase
oxidative glucose metabolism (Lewandowski et al., 2020), which
we measured in islet b cells from CDK2-iKO mice and controls
using three distinct assays.
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Figure 4. Increased islet recruitment underlies enhanced insulin secretion following short-term CDK2 restriction
(A) Representative recordings of cytosolic calcium oscillations in islets isolated from 4 Con and 4 CDK2-iKO mice stimulated by 10G or 7 mM glucose (7G).
(B) Percentage of islets that continued oscillating at 7G (Con, n = 89; CDK2-iKO, n = 95).
(C and D) CDK2-iKO increased the duty cycle (C) and reduced the period (D) of glucose-stimulated calcium oscillations (Con, n = 168 islets; CDK2-iKO, n = 182
islets).
(E) Representative recordings of cytosolic calcium oscillations in vehicle- or CDK2i-treated islets isolated from 2 wild-type (WT)/B6J mice stimulated by 10G.
(F) Percentage of islets that oscillated at 6 mM glucose (vehicle Con, n = 30; CDK2i, n = 32).
(G and H) CDK2i increased the duty cycle (G) and reduced the period (H) of glucose-stimulated calcium oscillations (vehicle Con, n = 40; CDK2i, n = 44).
(I) Representative recordings of cytosolic calcium response to 10 mM glyceraldehyde (10GA) at 2 mM glucose (2G) in islets isolated from 3 Con and 3 CDK2-iKO
mice.
(J and K) CDK2-iKO increased the duty cycle (J) and reduced the period (K) of glyceraldehyde-stimulated calcium oscillations (Con, n = 34; CDK2-iKO, n = 29).
(L) Representative recordings of cytosolic calcium response to 10 mM a-ketoisocaproate (10aKIC) at 2G in islets isolated from 2 Con and 2 CDK2-iKO mice.
(M andN) CDK2-iKO increased the duty cycle (M) and reduced the period (N) of keto-isocaproate-stimulated calcium oscillations (Con, n = 29; CDK2-iKO, n = 24).
Data are shown as mean ± SEM. #p < 0.1, ****p < 0.0001 by t test.




A B C Figure 5. Amino acid-stimulated PEP cycling
is sufficient to enhance islet recruitment in
CDK2-iKO islets
(A) PEP can be generated from glycolytic enolase or
from mitochondrial oxaloacetate conversion via
PCK2 and export to the cytosol. Addition of amino
acids fuels the TCA cycle and activates the PEP
cycle, and pyruvate kinase activator (PKa) also ac-
tivates the PEP cycle.
(B) Representative recordings of cytosolic calcium
elevation in response to an amino acid ramp at 2G
and in the absence (left) or presence (right) of PKa in
islets isolated from 3 Con and 3 CDK2-iKO mice. At 13, physiological amino acids (PAA) is (in mM) 2,100 alanine, 600 glutamine, 700 glycine, 550 valine, 500
leucine, 350 serine, 200 arginine, 218 lysine, and 121 threonine.
(C) Quantification of (B) by AUC at 23 mixed amino acids, normalized to Con/vehicle. (Con/vehicle, n = 44; CDK2-iKO/vehicle, n = 48; Con/PKa, n = 38; CDK2-
iKO/PKa, n = 44).
Data are shown as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 by one-way ANOVA.
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OPEN ACCESSNADH utilization is increased in CDK2-deficient islets
To investigate mitochondrial metabolism in the CDK2-iKO
model, we performed NAD(P)H fluorescence lifetime imaging
(FLIM) using the assay we developed to estimate NADH utiliza-
tion by the electron transport chain in intact islets (Gregg et al.,
2016, 2019). NAD(P)H lifetime is strongly dependent on the
microenvironment of each coenzyme as it binds to protein,
yielding a spatial display of islet redox metabolism (Figure 6A).
With this technique, relative fractional compositions of bound:
free NAD(P)H can be measured using the phasor approach (Dig-
man et al., 2008) as the peak position along the 1-g axis (Gregg
et al., 2016). In the presence of low and high glucose, the phasor
peak was lower along the 1-g axis in CDK2-iKO islets relative to
controls (Figure 6C), reflecting increased NADH consumption,
measured as a decrease in the fraction of bound:free NAD(P)H.
Lactate production is increased in CDK2-deficient b
cells
Lactate production is understood to be counterproductive in b
cells, where low levels of lactate dehydrogenase prevent
glucose utilization from accelerating under anaerobic conditions
(i.e., the Pasteur effect) to facilitate tight coupling of cytosolic and
mitochondrial fluxes (MacDonald, 1981; Schuit et al., 1997; Zhao
et al., 2001). Because there is no mechanism of lactate con-
sumption aside from pyruvate regeneration by lactate dehydro-
genase, lactate levels are dependent on the glycolytic rate of
NADH production (by GAPDH) and, thus, appropriate for testing
whether b cell CDK2 depletion affects glycolytic flux, keeping in
mind that mitochondrial substrate utilization may accelerate
glycolysis (Civelek et al., 1996)(McKenna et al., 2016). To assess
the cytosolic lactate levels specifically in islet b cells, we used an
adenovirus harboring the insulin promoter to express the fluores-
cence resonance energy transfer (FRET)-based lactate sensor
Laconic (San Martı́n et al., 2013; Figure 6D). In response to
10 mM glucose, steady-state oscillations in lactate were in
phase with cytosolic Ca2+, measured simultaneously, and
glucose reduction was accompanied by a reduction in lactate
(Figure 6E). Lactate production is therefore highest after mem-
brane depolarization and calcium influx, when NADH and
oxygen consumption are alsomaximal (Jung et al., 2000; Lewan-
dowski et al., 2020). Application of high glucose or lactate to the
bath solution increased cytosolic lactate, although only glucose
was sufficient to trigger a rise in NAD(P)H,membrane depolariza-6 Cell Reports 34, 108690, January 26, 2021tion, and calcium influx (Figure 6E). In comparison, application of
pyruvate induced only a modest increase in cytosolic lactate,
NAD(P)H, and calcium (Figure 6E), consistent with low levels of
lactate dehydrogenase and monocarboxylate transporters in
b cells, in addition to an unfavorable NADH/NAD+ ratio for pyru-
vate conversion to lactate. Based on these control data, the
enhancement of cytosolic lactate levels in CDK2-iKO islet b cells
relative to MIP-CreERT controls (Figure 6F) is consistent with an
increased glycolytic rate in CDK2-iKO b cells at low and high
glucose, matching the NAD(P)H-FLIM assay. Given that glucose
and glyceraldehyde (which enters glycolysis downstream of
glucokinase) have similar effects on calcium in CDK2-iKO islets
(Figure 4), the high lactate flux in these b cells more likely reflects
the workload-dependent pull of glycolytic substrate into mito-
chondria rather than an increased push of excess fuel through
glucokinase.
Reduced mitochondrial membrane potential (DJm) in
CDK2-deficient islets
As a third direct measurement of oxidative metabolism in b cells,
we measured DJm using Rhodamine-123 in non-quenching
mode, which utilizes low (nanomolar) dye concentrations so
that hyperpolarized (more negative) mitochondria will have
higher dye concentrations and fluorescence (Perry et al.,
2011). Although TMRM has been used to calculate absolute
DJm in dispersed b cells, this dye was avoided because of its
lower dynamic range (DJm oscillations were poorly resolved),
and because of the fast redistribution of TMRM across mem-
branes is confounded by plasma membrane depolarization
(which must be monitored independently) (Gerencser, 2015;
Gerencser et al., 2016). Although Rhodamine-123 must be
used cautiously in quench mode because changes in its quench
limit in response to ATP synthase inhibition with oligomycin (Ger-
encser et al., 2016), we validated non-quenchmode Rhodamine-
123 in intact islets using the same cocktail of inhibitors.
Phase-locked oscillations in DJm and NAD(P)H were
observed in the presence of 10 mM glucose (Figure 6G). Using
parallel measurements of NAD(P)H and calcium to relate DJm
to plasma membrane depolarization, we observed that DJm
builds up (hyperpolarizes) prior to plasmamembrane depolariza-
tion and is consumed (depolarized) shortly after plasma mem-
brane depolarization (Figure 6G), consistent with maximal
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Figure 6. Enhanced metabolism in CDK2-iKO islets
(A) Representative NAD(P)H fluorescence lifetime images from Con and CDK2-iKO islets imaged in 10G. Scale bar, 5 mM.
(B) Phasor histograms showing the frequency distribution of NAD(P)H lifetimes (1-g, s) in islets isolated fromCon (n = 4) and CDK2-iKO (n = 4)mice imaged in 10G.
(C) Projection of the phasor histogram peak along the 1-g axis was used to quantify NAD(P)H utilization in the presence of 2G, 10G, and complex I inhibitor (5 mM
rotenone [Rot], 15 min) as indicated (n = 10 islets per mouse for each condition).
(D) Maximum intensity projection of intact islet expressing Ad-RIP-Laconic in b cells imaged using a 2-photon Nikon TE-300 inverted confocal microscope.
(E) Left: response of each metabolite to 10G (n = 10 islets), 20 mM lactate (n = 12 islets), or 20 mM pyruvate (n = 10 islets) in islets isolated from 1WT/B6J mouse,
normalized to baseline signal at 2G. Scale bars, 2% baseline. Right: representative traces demonstrating the phase relationship between oscillations in NAD(P)H
(endogenous, blue trace; scale bar, 200 IU), cytosolic lactate (Ad-RIP-Laconic, black trace; scale bar, 0.02 R470/535 m), and cytosolic calcium (FuraRed, red
trace; scale bar, 0.05R 430/5003) at 10G and 2G.
(F) Increased lactate levels in CDK2-iKO islets (n = 59 islets from 3 mice) relative to Con (n = 72 islets from 4 mice) at 2G and 10G. Scale bar, 0.01 R470/535 m.
(G) Phase relationships between oscillations in NAD(P)H andDJm (left) and cytosolic calcium (right). NAD(P)H: black scale bar, 100 IU (left) or 500 IU (right).DJm:
red scale bar, 50 IU. FuraRed (Ca2+): red scale bar, 0.2 R430/5003.
(H) Response of DJm (red traces) and NAD(P)H (black traces) to the ETC inhibitors antimycin A (AntA; 1 mM, n = 10 islets), valinomycin (Val; 1 mM, n = 11 islets),
and oligomycin (Oligo; 2 mM, n = 12 islets); to 10G (n = 11 islets); and to 5mM cyanide (n = 11 islets) in islets isolated from 1WT/B6Jmouse.DJm is normalized to
fluorescence after depolarization with MDC. NAD(P)H is normalized to fluorescence at the beginning of the recording. Scale bars, 0.1 normalized IU.
(legend continued on next page)






OPEN ACCESSet al., 2000). As a further validation of the DJm measurements,
we then evaluated each component of a mitochondrial depolar-
ization cocktail (MDC) containing 2 mM oligomycin (a complex V
inhibitor), 1 mMantimycin A (a complex III inhibitor), and 1 mM va-
linomycin (a potassium ionophore) (Gerencser et al., 2016). We
also observed the expected hyperpolarization of DJm in
response to high glucose and depolarization in response to
KCN to a similar extent as to the MDC (Figure 6H). Because
KCN induced an equivalent depolarization as the MDC, it was
used to normalize the Rhodamine-123 signal measured in con-
trol and CDK2-iKO islets. In the presence of stimulatory glucose,
CDK2-iKO islets were significantly more depolarized than
control islets (Figure 6I), consistent with a more active electron
transport chain. The NAD(P)H FLIM, cytosolic lactate, and
DJm measurements identify a multi-site increase in oxidative
glucose metabolism in CDK2-deficient b cells as necessary to
support the observed increases in glucose-stimulated calcium
influx and insulin secretion.
DISCUSSION
These data provide genetic and pharmacologic evidence for
regulation of metabolism, ion channels, and insulin secretion
by CDK2 in adult b cells. Overall, we find that CDK2 suppresses
oxidative glucose metabolism and insulin secretion and plays an
essential role in supporting themetabolic signals associatedwith
fuel surfeit known as the metabolic amplifying pathways. It is un-
likely that these mechanisms are secondary to b cell decline
because our studies were conducted in the context of enhanced
insulin secretion and improved glucose tolerance in the CDK2-
iKO model. We further demonstrate that CDK2 blockade in-
creases b cell recruitment and identify two interdependent
mechanisms of this regulation, restricted KATP conductance
and enhanced mitochondrial PEP cycling, revealing that CDK2
signaling influences b cell sensing of glucose and amino acids.
The genetic link between CDK2, KATP channels, and secretion
is supported by prior studies in E2f1/ mice, where Kir6.2 was
identified as a transcriptional target of the CDK-RB-E2F
signaling pathway (Annicotte et al., 2009), as well as in Cdk2fl/
fl:Pdx1-Cremice (Kim et al., 2017). We also observed a reduction
in Kir6.2mRNA levels in CDK2-iKO islets and islets treated over-
night with a CDK2i, in parallel with a reduction in KATP conduc-
tance and increased calcium influx. However, in contrast with
developmental knockout, deleting CDK2 from mature b cells
improved glucose tolerance because of increased insulin secre-
tion. These data raise the possibility that embryonic deletion of
CDK2 induces a time-dependent or developmental defect in
the islet, whereas CDK2 signaling in adult b cells suppresses in-
sulin secretion. Hyperexcitability, which can be found in all CDK2
depletion models, including Cdk2fl/fl:Pdx1-Cre (unpublished
data), may explain the ultimate decline in insulin secretion in
these mice as well as in E2f1/ mice.
In our models of short-term CDK2 restriction, we observe that
the consequences of reducing KATP channel conductance(I)DJm is depolarized in CDK2-iKO islets (n = 70 islets from 3mice) relative to Con
with cyanide, quantified as percentage of baseline. Scale bar, 0.2 normalized IU
Data are shown as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.000
8 Cell Reports 34, 108690, January 26, 2021include enhanced glucose-stimulated b cell recruitment and,
thus, an elevated calcium duty cycle. It is possible that other
CDK2 targets not identified in this study contribute to b cell
recruitment. Indeed, if reduced GKATP was the sole effector of
CDK2 depletion, then the calcium oscillation period would be ex-
pected to increase in a fashion similar to glucose elevation.
Instead, CDK2 depletion strongly increased the cycling fre-
quency. A recently discovered mechanism of b cell recruitment
that increases cycling frequency is PEP and ADP conversion to
pyruvate and ATP byPK,which can raisemean calciumprovided
a net synthesis of PEP is generated viamitochondrial anaplerosis
(Lewandowski et al., 2020).Mitochondria-derived PEP produced
by PCK2 is required for full insulin secretion in INS1 cells and
mice (Abulizi et al., 2020; Stark et al., 2009). In CDK2-iKO islets,
enhanced b cell recruitment persisted when b cells were pro-
vided with glucose or glyceraldehyde to generate glycolytic
PEP or, orthogonally, anaplerotic fuels (here, aKIC or amino
acids) that increase mitochondrial PEP production and cytosolic
PK-driven KATP closure at low glucose (Abulizi et al., 2020; Lew-
andowski et al., 2020). When PEP cycling was driven maximally
by pharmacological PK activation and amino acids, enhanced
PEP cycling in CDK2-deficient cells synergized with the reduc-
tion in GKATP, driving a further increase in fuel sensitivity. In vivo,
amino acids would be expected to augment b cell recruitment by
glucose and contribute to the enhanced glucose tolerance
observed in CDK2-iKO mice.
Multi-site measurements of lactate, NAD(P)H, and DJm in
living b cells indicate that CDK2 depletion augments oxidative
glucose metabolism. Increased glucokinase flux (a ‘‘push’’
mechanism) is unlikely to explain these effects because down-
stream glycolytic and mitochondrial fuels (glyceraldehyde and
aKIC) had effects on calcium oscillations comparable with
glucose. A more compelling alternative (Figure 7) is that ADP-
dependent oxidative phosphorylation is driven up in CDK2-defi-
cienct b cells by the increased workload (ATP turnover) associ-
ated with elevated calcium and secretion, consuming DJm. In
this case, mitochondrial NADH and cytosolic lactate depletion
are dependent on increased mitochondrial substrate utilization,
as needed to maintain DJm (Civelek et al., 1996; McKenna
et al., 2016). To validate this interpretation of our oxidative meta-
bolic assays, we used glucose-stimulated calcium oscillations
as a tool to understand the relationships between oxygen con-
sumption, DJm, and lactate. Our observations fit prior studies
demonstrating that oxidative phosphorylation is controlled by
ADP availability in b cells (Civelek et al., 1997; Jung et al.,
2000; Lewandowski et al., 2020), produced by an increase in
ATP turnover in the cell during periods of high calcium (Ainscow
and Rutter, 2002; Doliba et al., 2003; Panten et al., 1986; Sweet
et al., 2004; Affourtit et al., 2018). Here we demonstrated con-
sumption of DJm during periods of high calcium during
glucose-stimulated oscillations and further measured a depolar-
ized DJm in CDK2-iKO islets, corroborating previous studies
connecting DJm to CDK2 signaling in proliferating cells (Mitra
et al., 2009; Schieke et al., 2008).islets (n = 85 islets from 4mice), normalized to fluorescence after depolarization
.
1 by one-way AVOVA (C) or t test (F and I).
Figure 7. Model of CDK2 regulation of b cell metabolism
CDK2 regulates b cell excitability, oxidative metabolism, and insulin secretion.
CDK2 activates KATP channel conductance independent of the PEP source.
KATP channel activation limits b cell excitability and calcium influx, which al-
leviates ATP consumption by exocytosis and calcium removal through calcium
ATPases, limiting oxidative metabolism. Additionally, CDK2 promotes meta-
bolic amplification of insulin secretion.
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driven system may also explain why glucose fails to fully amplify
secretion when CDK2 is depleted. Although other cell cycle reg-
ulators have been shown to act directly on exocytotic machinery
(Bembenek et al., 2007; Xin et al., 2004), such a generalizable
defect cannot explain our findings because CDK2 deletion had
no effect KCl-stimulated insulin secretion at low glucose. Rather,
the disconnect between triggering and amplification in the
CDK2-iKOmodel highlights the fundamental difference between
oxidative metabolism driven by calcium influx (a metabolic
‘‘pull’’) and oxidative metabolism stimulated by excess fuel (a
metabolic ‘‘push’’) that supports amplification. Fuel surfeit,
which would not be supported by the lowDJmand NADH found
in CDK2-deficient b cells, is necessary to generate metabolic
coupling factors (e.g., reactive oxygen species) that potentiate
secretion (Leloup et al., 2009; Prentki et al., 2013). Loss of
KATP channel conductance in CDK2-iKO b cells may induce a
calcium-driven workload (ATP turnover) that consumes meta-
bolic substrates and reduces the metabolic capacitance that
benefits amplification (Figure 7).
In addition to CDK2, CDK1 (Gregg et al., 2019), CDK5 (Wei
et al., 2005), and CDK8 (Xue et al., 2019) have been found to
regulate glucose-stimulated insulin secretion. Additionally, the
CDK regulator p16/INK4a (Helman et al., 2016; Zheng et al.,
2013) and the effector molecule c-MYC (Puri et al., 2018; Rosse-
lot et al., 2019) have demonstrated significant control over insulin
secretion in addition to established canonical cell cycle control of
proliferation. Our results provide further evidence that CDK2 can
modify the metabolic and secretory state independent of matu-
ration defects reflected by MAFA, GLUT2, or UCN3 (Blum et al.,
2012; Hang et al., 2014; van der Meulen et al., 2015).
Limitations of study
It is likely that the phenotypes observedhere are the result of com-
plex, CDK2-dependent transcriptional regulation and post-trans-lationalmodification thatwerenot identified in this study.Although
CDK2 may act through the RB-E2F pathway to transcriptionally
regulate Kir6.2 mRNA levels, further experiments are necessary
to confirm thismechanism in adult b cells, whereCDK2was found
primarily in the cytosol. Although the CDK2 ablation results in gain
of function, it remains possible that, in theCDK2-iKOmodel, there
is enhanced, compensatory activity of other cell cycle regulators
(Fiaschi-Taeschetal., 2013).Our findingshighlight the importance
of CDK2 regulation ofmetabolism, ion channel function, and insu-
lin secretion in mature b cells.
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mengol, J., Jimenez, V., Chavey, C., Giralt, A., Lai, Q., Zhang, L., et al. (2016).
CDK4 is anessential insulin effector in adipocytes. J.Clin. Invest.126, 335–348.
Lane,M.E., Yu, B., Rice, A., Lipson, K.E., Liang, C., Sun, L., Tang, C.,McMahon,
G.,Pestell,R.G., andWadler,S. (2001).Anovelcdk2-selective inhibitor,SU9516,
induces apoptosis in colon carcinoma cells. Cancer Res. 61, 6170–6177.
Lee, Y., Dominy, J.E., Choi, Y.J., Jurczak, M., Tolliday, N., Camporez, J.P.,
Chim, H., Lim, J.-H., Ruan, H.-B., Yang, X., et al. (2014). Cyclin D1-Cdk4 con-
trols glucose metabolism independently of cell cycle progression. Nature 510,
547–551.
Leloup, C., Tourrel-Cuzin, C., Magnan, C., Karaca, M., Castel, J., Carneiro, L.,
Colombani, A.-L., Ktorza, A., Casteilla, L., and Pénicaud, L. (2009). Mitochon-
drial reactive oxygen species are obligatory signals for glucose-induced insulin
secretion. Diabetes 58, 673–681.
Lewandowski, S.L., Cardone, R.L., Foster, H.R., Ho, T., Potapenko, E., Pou-
del, C., VanDeusen, H.R., Sdao, S.M., Alves, T.C., Zhao, X., et al. (2020). Py-
ruvate Kinase Controls Signal Strength in the Insulin Secretory Pathway. Cell
Metab. 32, 736–750.e5.
Lopez-Mejia, I.C., Lagarrigue, S., Giralt, A., Martinez-Carreres, L., Zanou, N.,
Denechaud, P.-D., Castillo-Armengol, J., Chavey, C., Orpinell, M., Delacui-
sine, B., et al. (2017). CDK4 Phosphorylates AMPKa2 to Inhibit Its Activity
and Repress Fatty Acid Oxidation. Mol. Cell 68, 336–349.e6.
MacDonald, M.J. (1981). High content of mitochondrial glycerol-3-phosphate
dehydrogenase in pancreatic islets and its inhibition by diazoxide. J. Biol.
Chem. 256, 8287–8290.
McKenna, J.P., Ha, J., Merrins, M.J., Satin, L.S., Sherman, A., and Bertram, R.
(2016). Ca2+ Effects on ATP Production and Consumption Have Regulatory
Roles on Oscillatory Islet Activity. Biophys. J. 110, 733–742.
Merrins, M.J., and Stuenkel, E.L. (2008). Kinetics of Rab27a-dependent ac-
tions on vesicle docking and priming in pancreatic beta-cells. J. Physiol.
586, 5367–5381.
Mitra, K., Wunder, C., Roysam, B., Lin, G., and Lippincott-Schwartz, J. (2009).
A hyperfused mitochondrial state achieved at G1-S regulates cyclin E buildup
and entry into S phase. Proc. Natl. Acad. Sci. USA 106, 11960–11965.
Oropeza, D., Jouvet, N., Budry, L., Campbell, J.E., Bouyakdan, K., Lacombe,
J., Perron, G., Bergeron, V., Neuman, J.C., Brar, H.K., et al. (2015). Phenotypic
Characterization of MIP-CreERT1Lphi Mice With Transgene-Driven Islet
Expression of Human Growth Hormone. Diabetes 64, 3798–3807.
Panten, U., Z€unkler, B.J., Scheit, S., Kirchhoff, K., and Lenzen, S. (1986). Regu-
lation of energy metabolism in pancreatic islets by glucose and tolbutamide.
Diabetologia 29, 648–654.
Perry, S.W., Norman, J.P., Barbieri, J., Brown, E.B., and Gelbard, H.A. (2011).
Mitochondrial membrane potential probes and the proton gradient: a practical
usage guide. Biotechniques 50, 98–115.
Prentki, M., Matschinsky, F.M., and Madiraju, S.R.M. (2013). Metabolic
signaling in fuel-induced insulin secretion. Cell Metab. 18, 162–185.
Puri, S., Roy, N., Russ, H.A., Leonhardt, L., French, E.K., Roy, R., Bengtsson,
H., Scott, D.K., Stewart, A.F., and Hebrok, M. (2018). Replication confers b cell
immaturity. Nat. Commun. 9, 485.Ren, J., Sherman, A., Bertram, R., Goforth, P.B., Nunemaker, C.S., Waters,
C.D., and Satin, L.S. (2013). Slow oscillations of KATP conductance in mouse
pancreatic islets provide support for electrical bursting driven bymetabolic os-
cillations. Am. J. Physiol. Endocrinol. Metab. 305, E805–E817.
Rosselot, C., Kumar, A., Lakshmipathi, J., Zhang, P., Lu, G., Katz, L.S., Pro-
chownik, E.V., Stewart, A.F., Lambertini, L., Scott, D.K., and Garcia-Ocaña,
A. (2019). Myc Is Required for Adaptive b-Cell Replication in Young Mice but
Is Not Sufficient in One-Year-Old Mice Fed With a High-Fat Diet. Diabetes
68, 1934–1949.
Sakamaki, T., Casimiro, M.C., Ju, X., Quong, A.A., Katiyar, S., Liu, M., Jiao, X.,
Li, A., Zhang, X., Lu, Y., et al. (2006). Cyclin D1 determines mitochondrial func-
tion in vivo. Mol. Cell. Biol. 26, 5449–5469.
San Martı́n, A., Ceballo, S., Ruminot, I., Lerchundi, R., Frommer, W.B., and
Barros, L.F. (2013). A genetically encoded FRET lactate sensor and its use
to detect the Warburg effect in single cancer cells. PLoS ONE 8, e57712.
Schieke, S.M., McCoy, J.P., Jr., and Finkel, T. (2008). Coordination of mito-
chondrial bioenergetics with G1 phase cell cycle progression. Cell Cycle 7,
1782–1787.
Schuit, F., De Vos, A., Farfari, S., Moens, K., Pipeleers, D., Brun, T., and Pren-
tki, M. (1997). Metabolic fate of glucose in purified islet cells. Glucose-regu-
lated anaplerosis in beta cells. J. Biol. Chem. 272, 18572–18579.
Stark, R., Pasquel, F., Turcu, A., Pongratz, R.L., Roden, M., Cline, G.W., Shul-
man, G.I., and Kibbey, R.G. (2009). Phosphoenolpyruvate cycling via mito-
chondrial phosphoenolpyruvate carboxykinase links anaplerosis and
mitochondrial GTP with insulin secretion. J. Biol. Chem. 284, 26578–26590.
Sweet, I.R., Cook, D.L., DeJulio, E., Wallen, A.R., Khalil, G., Callis, J., and Re-
ems, J. (2004). Regulation of ATP/ADP in pancreatic islets. Diabetes 53,
401–409.
Tamarina, N.A., Roe, M.W., and Philipson, L. (2014). Characterization of mice
expressing Ins1 gene promoter driven CreERT recombinase for conditional
gene deletion in pancreatic b-cells. Islets 6, e27685.
Thorens, B., Tarussio, D., Maestro, M.A., Rovira, M., Heikkilä, E., and Ferrer, J.
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Antibodies
Guinea Pig Polyclonal Anti-Insulin Agilent Cat#A056401-2; RRID: AB_2617169
Rabbit Polyclonal Anti-Glucagon Cell Signaling Technology Cat#2760; RRID: AB_659831
Rabbit Monoclonal Anti-MAFA Cell Signaling Technology Cat#79737; RRID: AB_2799938
Rabbit Polyclonal Anti-Urocortin III Phoenix Pharmaceuticals Cat#H-019-29
Rabbit Polyclonal Anti-GLUT-2 Sigma-Aldrich Cat#07-1402; RRID: AB_1587076
Rabbit Monoclonal Anti-Ki-67 Cell Signaling Technology Cat#9129; RRID: AB_2687446
Alexa Fluor 488 AffiniPure Donkey Anti-
Rabbit IgG (H+L)
Jackson ImmunoResearch Cat#711-545-152; RRID: AB_2313584
Alexa Fluor 647 AffiniPure Donkey Anti-
Guinea Pig IgG (H+L)
Jackson ImmunoResearch Cat#706-605-148; RRID: AB_2340476
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RPMI-1640 cell culture media Sigma-Aldrich Cat#R8758
Fetal bovine serum Thermo Fisher Cat#A31605
Penicillin-Streptomycin (10,000U/mL) Fisher Scientific Cat#5140122
SU9516 Enzo Life Sciences Cat#ALX-270-400; CAS: 377090-84-1
SYBR Green PCR Master Mix Thermo Fisher Cat#4364346
DMEM Sigma-Aldrich Cat#D5030
Rat/Mouse Insulin Standard Millipore Cat#E8013-k
Streptavidin protein, HRP Thermo Scientific Cat#21126
o-phenylenediamine Millipore Sigma Cat#P5412; CAS: 95-54-5
FuraRed Invitrogen Cat#F3020; CAS: 179732-62-7
Rhodamine-1,2,3 Invitrogen Cat#R302; CAS: 62669-70-9
Amphotericin B Sigma-Aldrich Cat#A4888; CAS: 1397-89-3
Diazoxide Sigma-Aldrich Cat#D9035; CAS: 364-98-7
Accutase Sigma-Aldrich Cat#A6964
Normal Donkey Serum Jackson ImmunoResearch Cat#017-000-121; RRID: AB_2337258
TEPP-46 (PKa) MilliporeSigma Cat#50-548-70001; CAS: 1221186-53-3
Antimycin A Sigma-Aldrich Cat#A8674; CAS: 1397-94-0
Valinomycin Sigma-Aldrich Cat#V0627; CAS: 2001-95-8
Oligomycin Sigma-Aldrich Cat#75351; CAS: 579-13-5
Potassium Cyanide Sigma-Aldrich Cat#60178; CAS: 151-50-8
Coumarin Sigma-Aldrich Cat#C4261; CAS: 91-64-5
Rotenone Sigma-Aldrich Cat#R8875; CAS: 83-79-4
Critical commercial assays
RNeasy RNA extraction kit QIAGEN Cat#74104




B6.Cg-Tg(Ins1-cre/ERT)1Lphi/J mice The Jackson Laboratory JAX: 024709
Cdk2fl/fl mice Jayapal et al., 2015 N/A
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Bhalla et al., 2014 N/A
Primer: b-Actin Reverse:
GTGGTGGTGAAGCTGTAGCC
Bhalla et al., 2014 N/A
Recombinant DNA
b-cell specific Laconic Lactate biosensor Lewandowski et al., 2020 N/A
Ad-CMV-Cre-IRES-GFP Vector Biolabs Cat#1710
Software and algorithms
NIS-Elements Nikon Instruments https://www.microscope.healthcare.nikon.
com/products/software/nis-elements
MATLAB Software Mathworks https://www.mathworks.com/products/
matlab.html
FIJI ImageJ https://imagej.net/Fiji




GraphPad Prism 7.0 Graphpad Software https://www.graphpad.com/
scientific-software/prism/
Other
StepOne Plus Real-Time PCR System Applied Biosystems Cat#4376600
Plate Reader Infinite M1000 Pro TECAN Cat#30063849
10X/0.5NA SuperFluor Objective Nikon Instruments Cat#MRF00100
60X/1.4NA Plan Apochromat Objective Nikon Instruments Cat#MRD01605
SOLA SE-5-LCR-VA Lumencor N/A
FF444/521/608-Di01 dichroic beamsplitter Semrock Cat#FF444/521/608-Di01-25x36
ORCA-Flash4.0 V2 Hamamatsu Cat#C11440-22CU
HEKA EPC10 patch-clamp amplifier Heka N/A
MaiTai HP DeepSee TI:Sapphire Laser Spectra-Physics N/A
Time-Correlated Single Photon Counting
module
Becker & Hickl Cat#SPC-830





Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Matthew
Merrins (mmerrins@medicine.wisc.edu).
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OPEN ACCESSEXPERIMENTAL MODEL AND SUBJECT DETAILS
All experiments performed with laboratory animals were performed according to the guidelines of the Institutional Animal Care and
Use Committees of the University of Wisconsin-Madison and the William S. Middleton Memorial Veterans Hospital, and followed the
NIH Guide for the Care and Use of Laboratory Animals (8th ed. The National Academies Press. 2011.). Cdk2fl/fl mice (Kim et al., 2017;
Jayapal et al., 2015) were crossed withMIP-CreERTmice (Jax 024709) (Tamarina et al., 2014) to generate a b-cell specific Cdk2 dele-
tion mouse (CDK2-iKO). To properly control for the ectopic expression of human growth hormone (hGH) and CreERT in b-cells
(Brouwers et al., 2014; Oropeza et al., 2015), and the independent effects of tamoxifen (Ahn et al., 2019; Carboneau et al., 2016),
all mice studied were CreERT-positive and tamoxifen-injected. While Ins1-CreER mice (Jax 026802) are also b-cell specific and
lack hGH (Thorens et al., 2015), they failed to catalyze loxP excision and we continued with the MIP-CreERT strain. Male mice
were housed 1-4 per cage at 21-23C,maintained on a 12 hour light/dark cycle (light on 6:00AM to 6:00PM), with chow diet andwater
provided ad libitum. 10 week old mice received intraperitoneal injections of tamoxifen (4 mg in 200 mL sunflower seed oil) three times
over five days to induce Cre-mediated recombination. Mice were analyzed four weeks after the final injection to allow tamoxifen
clearance. Cre-mediated deletion of Cdk2 exons 4-5 was confirmed by qPCR (primers are listed below).
METHOD DETAILS
Glucose Tolerance Test
Glucose tolerance was measured after an overnight fast by intraperitoneal injection of 2 g/kg glucose. Blood glucose was measured
using a Bayer Contour glucometer at 0, 15, 30, 45, 60, and 120 minutes post-injection.
Pancreas Fixation
Dissected pancreata from 12 week old mice were fixed in 4% PFA diluted in PBS for 3 hours at 4C. Fixed pancreata were then
washed in PBS for 1 hour at room temperature. Following the wash, pancreata were equilibrated in 30% (w/v) sucrose in PBS for
1 hour, followed by embedding in OCT with subsequent freezing on dry ice.
Immunostaining
Slides with 10 mm thick pancreas sections were blocked in 10% Normal Donkey Serum (Jackson) diluted in 0.2% PBST (PBS, 0.2%
Triton X-100) for one hour at room temperature. Following block, slides where incubated with primary antibodies diluted in 10%
Normal Donkey Serum overnight at 4C. Slides were then washed 3 3 10 mins with 0.2% PBST and then incubated with secondary
antibodies diluted in 10% Normal Donkey Serum for one hour at room temperature. Slides were then washed 3 3 10 minutes with
0.2% PBST. Primary antibodies used were Guinea pig anti-Insulin (1:6 Agilent), Rabbit anti-glucagon (1:200 CST), Rabbit anti-MafA
(1:100, CST), Rabbit anti-Ucn3 (1:500, Phoenix), Rabbit anti-Glut2 (1:400, Sigma), and Rabbit anti-Ki67 (1:400; CST). Secondary an-
tibodies used were Donkey anti Rabbit-488 (Jackson), and Donkey anti-Guinea pig 647 (Jackson).
a-Cell and b-cell Mass Measurement
For eachmouse (n = 4-5 per genotype), eight 10 mm thick whole pancreas sections, each 150 mmapart, were stained with Guinea pig
anti-insulin (Agilent), Rabbit anti-glucagon (CST), and DAPI. Whole sections were then imaged on a Nikon A1RS confocal microscope
at 10x magnification. The area of insulin, glucagon, and DAPI staining was measured in mm2 using FIJI’s auto thresholding and Anal-
zeParticles functions. b-Cell and a-cell mass were determined for each animal by dividing the sum of insulin or glucagon area across
all sections imaged by the sum of the area of DAPI across those same sections.
Cell Proliferation Analysis
For eachmouse (n = 4-5 per genotype) four to five 10 mm thickwhole pancreas sections, each 150 mmapart, were stainedwith Guinea
pig anti-insulin (Agilent), Rabbit anti-ki67 (CST), and DAPI. 18-26 islets with at least 3 coming from each section were imaged using a
Nikon A1RS confocal microscope at 20x magnification. Ki-67 +/Insulin+ cells in all islets from eachmouse were counted and divided
by the sum of insulin area across the same islets to determine the relative beta cell proliferation in each mouse.
Islet isolation
Mouse pancreas was inflated with 3-5 mL of 0.67mg/mL collagenase (Sigma) and 0.2 mg/mL BSA in Hanks Buffered Salt Solution
(HBSS) (Invitrogen). After excision, pancreas was incubated in a glass vial of 5mL collagenase/BSA/HBSS for 5 minutes on an orbital
shaking water bath at 250 rpm. At the 6th minute of incubation, pancreas was agitated for 20 s at 350 rpm every 2 minutes until 24 mi-
nutes of incubation. Pancreatic digests were washed three times with 30mL ice cold BSA/HBSS solution by pelleting at 50 g for 2mi-
nutes, aspirating 20-25mL supernatant, and resuspending in 5-10 mL of remaining BSA/HBSS solution by vortexing at medium
speed. Islets were hand-picked from acinar tissue in 40 mL ice cold BSA/HBSS solution and finally picked into RPMI 1640 (Sigma
Aldrich) supplemented with 10% FBS (v/v) (Thermo Fisher), 100 units/mL penicillin, and 100 ug/mL streptomycin (Fisher Scientific).
For experiments requiring adenovirus, islets were infected immediately post-isolation for 2 hours at 37C, then moved to fresh me-
dium overnight. Generation of Ad-RIP-Laconic was described previously (Lewandowski et al., 2020) and Ad-Cre-IRES-GFP ise3 Cell Reports 34, 108690, January 26, 2021
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OPEN ACCESScommercially available (Vector Biolabs 1710). For experiments requiring CDK2i, islets were incubated in media containing 5 mM
SU9516 (Enzo) or 0.1% DMSO vehicle overnight.
Quantitative PCR
Following a 16 hour recovery post-isolation, islets were collected andwashedwith PBS. RNAwas isolated using theQIAGENRNeasy
RNA extraction kit. 100 ug of RNA was reverse transcribed into cDNA using a cDNA reverse transcriptase kit (Applied Biosystems).
Quantitative PCR was performed in triplicate using the following primers: Cdk2: F (50-
AATTCTTCTGGGCTGCAAGTA-30), R (50-GGGTACACACTAGGTGCATTT-30); Kcnj11: F (50- GTGTCCAAGAAAGGCAACTG 30),
R (50- GCACAGGAAGGACATGGTG 30); normalized to a reference gene b-Actin: F (50-GAGACCTTCAACACCCC-30), R
(50GTGGTGGTGAAGCTGTAGCC-30). SYBR Green PCR Master Mix (Rox) (Roche) was used with 1 mL of cDNA per reaction with
a final primer concentration of 6 pM. Reactions were run on a StepOne Plus Real-Time PCR system (Applied Biosystems). PCR prod-
uct specificity was determined by melt-curve analysis and gel electrophoresis. Data was reported as DDCt.
Glucose-Stimulated Insulin Secretion
Glucose-stimulated insulin secretion wasmeasured in DMEM (Sigma D-5030) supplemented with 4 mM L-glutamine, 44mM sodium
bicarbonate, 10 mM HEPES and 0.2% BSA at 37C in 5% CO2. 60 islets per mouse were preincubated for 45 minutes in 2 mL of
DMEM containing 3.3 mM glucose. Six groups of 10 islets were then transferred to 12-well plates (CellTreat 229112) containing
1 mL of DMEM/3.3 mM glucose per well and were incubated for 45 minutes. Islets were then transferred to a new 12 well plate con-
taining 1 mL of DMEM containing 16.7 mM glucose, and were incubated for 45 minutes. Islets were then collected for content mea-
surements in 500 mL cell lysis buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 1% Triton-X. Secretion media was also
collected and all samples were frozen at 80C prior to insulin measurement by ELISA.
Insulin ELISA
ELISA was used to measure insulin secretion as a percentage of total islet insulin content. 96-well high-binding plates (Corning 3690)
were coated overnight with 3 mg/mL (50 mL/well) of anti-insulin primary antibody (Fitzgerald Industries International Research 10R-
I136a) diluted 1:2500 in PBS. Plates were blocked for 1 hour with 100 mL/well PBS containing 4% BSA (Sigma A-7888). Plates
were then emptied and 25 mL/well of insulin standards (Millipore 24304391/8013-k, 0.1-10ng/mL), secretion media, or islet lysate
were added to the plate and incubated for 1 hour. 25 mL/well of secondary antibody (Fitzgerald Industries International Research
10R-I136bBt) diluted 1:1000 in PBS with 1%BSAwas added to each well. Plates were gently mixed and incubated for 1 hour. Plates
were then emptied and rinsed three timeswith 100 mL/well wash buffer containing 50mMTris and 0.2%Tween-20, pH 8.0.Wellswere
incubated with 50 mL/well of 1 mg/mL of streptratavidin-HRP (Pierce 21126) in PBS with 0.1%BSA for 30 minutes. Plates were rinsed
three times with wash buffer before addition of 50 mL/well of 16 mM/mL of o-phenylenediamine (Sigma P-5412) dissolved in 0.1M cit-
rate-phosphate, 0.03% H2O2 at pH 5.0. The plate was allowed to develop for 3-5 minutes before quenching the reaction with 50 mL/
well of 18 mM sulfuric acid. Absorbance at 492 nm was measured by plate reader (TECAN Infinite M1000 Pro). Insulin content was
calculated by comparison to known standards. All products unlisted are from Sigma.
Timelapse Imaging
Biosensors were introduced for the following metabolites as follows: cytosolic calcium, 45-minute pre-incubation in 2.5 mMFuraRed
(Molecular Probes); mitochondrial membrane potential, 5-minute pre-incubation in 0.83 mMRhodamine-123 (Sigma); lactate, 2 hour
infectionwith 1 mL high-titer adenovirus immediately following isolation, then 2 days incubation in freshmedia. Islets were then placed
in a glass-bottom chamber (Warner Instruments) on a Nikon Eclipse Ti-E inverted microscope equipped with Super Flour 10x/0.5 NA
objectives (Nikon Instruments). The chamber was perfused with standard external solution containing (in mM): 135 NaCl, 4.8 KCl, 2.5
CaCl2, 1.2 MgCl2, 20 HEPES (pH 7.35) with metabolic fuels as indicated in the figures and figure legends. The flow rate was 0.3 mL/
min, and temperature was maintained at 33C using inline solution and chamber heaters (Warner Instruments). Excitation was pro-
vided by a SOLA SEII 365 (Lumencor) set to < 20% output. Fluorescence emission was collected with a Hamamatsu ORCA-Flash4.0
V2 Digital CMOS camera at 0.125-0.2 Hz. A single region of interest was used to quantify the average response of each islet using
Nikon NIS-Elements. For cytosolic calcium recordings, excitation (430/20x and 500/20x) and emission (630/70m) filters (ET type,
Chroma Technology Corporation) were used in combination with an FF444/521/608-Di01 dichroic (Semrock) and reported as an
excitation ratio (R430/500x). The same dichroic mirror was used for laconic sensor FRET imaging, with CFP excitation provided
by a 430/24x filter and emission filters 470/24m and 535/30m reported as an emission ratio (R470/535m). For mitochondrial mem-
brane potential recordings using Rhod123, the same dichroic mirror was used, with excitation provided by a 500/20x filter and a 535/
30m filter was used for emission light. A custom MATLAB script calculated cytosolic calcium R430/500x oscillation parameters
including the average duty cycle of each islet. Lactate measurements were normalized to baseline values in low glucose. Mitochon-
drial membrane potential values were normalized to baseline following depolarization.
NAD(P)H Fluorescence Lifetime Imaging
Islets were imaged in #1.5 glass-bottom dishes on a custom-built multiphoton laser scanning system based around a Nikon TE-300
inverted microscope equipped with a PlanApo 60X/1.4NA oil immersion objective (Nikon Instruments) in a standard external solutionCell Reports 34, 108690, January 26, 2021 e4
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OPEN ACCESS(above). Temperature was maintained at 35C using a LiveCell incubator (Pathology Devices). NAD(P)H was excited with Mai Tai
DeepSee Ti:Sapphire laser (Spectra-Physics) at 740 nm with a 450/70 m bandpass emission filter (Chroma) before collection by a
Hamamatsu H7422P-40 GaAsP photomultiplier tube. FLIM images were collected at 256x256 resolution with 120 s collection at
1 Hz using SPC-830 Time-Correlated Single Photon Counting (TCSPC) electronics (Becker & Hickl GbmH). In each experiment,
urea crystals were used to define the instrument response function with a 370/10m bandpass emission filter (Chroma), and coumarin
(Sigma) was used as a reference for lifetime (2.5 ns) using a 450/70m bandpass emission filter (Chroma). For analysis, raw SDT files
were imported intoMATLAB (MathWorks), and a custom script was used to generate phasor histograms for each treatment using the
equations in Digman et al. (2008). All data were reported as the phasor histogram peak (1-gmax). Glucose reduces 1-gmax reflecting
mitochondrial NADH consumption, as measured by an increase in NAD(P)H production and larger pool of free NAD(P)H. Addition of
the positive control, rotenone, blocks NADH consumption by complex I of the electron transport chain, reducing the fraction of
bound:free NAD(P)H and thus further reducing 1-gmax.
KATP conductance
b-cell membrane potential and KATP conductance were measured as in Ren et al. (2013). Briefly, a Sutter MP-225 micromanipulator
was used together with a HEKA EPC10 patch-clamp amplifier in the perforated patch-clamp configuration to record membrane po-
tential from intact islets perfused with standard external solution (above). Pipette tips were filled with an internal solution (in mM: 28.4
K2SO4, 63.7 KCl, 11.8 NaCl, 1MgCl2, 20.8 HEPES, 0.5 EGTA; 40 sucrose; pH 7.2) containing 0.36mg/ml amphotericin B. Islet b-cells
were identified by the presence of slow oscillations in 10 mM glucose. The amplifier was then switched into voltage clamp mode.
Conductance changes were determined from the current-voltage relation (I-V) using 2 s voltage ramps from 120 to 50 mV every
20 s during the silent phase of bursting and following application of 200 mm diazoxide (Sigma).
Exocytosis
b-cell Ca2+ current and exocytosis were measured as in Merrins and Stuenkel (2008) with minor changes. Briefly, a Sutter MP-225
micromanipulator was used together with a HEKA EPC10 patch-clamp amplifier (Heka Instruments, Bellmore, NY) in the whole cell
patch-clamp configuration to record Ca2+ current from intact islets perfusedwith standard external solution (above). Pipette tipswere
filledwith an internal solution (inmM: 125Cs-glutamate, 10CsCl, 10NaCl, 1MgCl2$6H2O, 0.05 EGTA, 5HEPES, 0.1 cAMP, 3MgATP;
pH 7.15 with CsOH). After membrane rupture, cell size was used to distinguish islet b-cells (> 5.5 pF) from a-cells (< 5 pF), and after
1 min Ca2+ current was quantified from a 15 ms depolarization from 70 to 0 mV followed by a P/4 leak subtraction protocol. After 1
additional min, exocytosis was stimulated by activating VDCCs with a series of ten 500 ms membrane depolarizations from 70 to
0 mV. Capacitance responses (fF) and Ca2+ currents (pA) were normalized to initial cell size (pF).
QUANTIFICATION AND STATISTICAL ANALYSIS
The statistical details of experiments can be found in the figure legends. Data are expressed asmeans ± SEM. Statistical significance
was determined using one- or two-way ANOVA with Sidak multiple-comparisons test post hoc or Student’s t test as appropriate.
Differences were considered to be statistically significant at p < 0.05. Statistical calculations were performed with GraphPad Prism.e5 Cell Reports 34, 108690, January 26, 2021
